News
GSK and Hengrui Pharma signed a global deal for up to 12 drugs, including COPD therapy, with milestone payments totaling $12 ...
2d
GlobalData on MSNHengrui Pharma and GSK link across key therapeutic areasHengrui Pharma has signed an agreement with GSK for the development of up to 12 innovative medicines across several ...
Most of the country is experiencing some nasty summer heat, so you can imagine our glee when we wiped the sweat out of our ...
New capital, maturing pipelines, and a more global R&D mindset are pushing valuations higher, even as competition tightens.
17h
Zacks Investment Research on MSNMerck Q2 Earnings Top, Sales Meet Estimates, 2025 View NarrowedMerck MRK reported second-quarter 2025 adjusted earnings per share (EPS) of $2.13, which beat the Zacks Consensus Estimate of ...
8don MSNOpinion
The other Rosado vote that Carollo disliked was the decision to terminate the Bayfront Park Management Trust in January of ...
“Petaluma Valley Hospital is not seeing higher-than-normal turnover for nurses,” the spokesperson said in an email. As the ...
Israel killed at least 53 people in Gaza overnight and into Saturday, Palestinian health officials and the ambulance service ...
On July 1, two men were hit by a white Cadillac Escalade as they crossed Petaluma Boulevard North, reportedly just after the ...
Things have gone from bad to worse for the company chosen by the state to run the Medicaid homecare program, commonly known ...
20d
Zacks Investment Research on MSNVerona Pharma Stock Jumps 20% on $10B Buyout Offer From MerckVerona Pharma VRNA has signed a definitive agreement with pharma bigwig Merck MRK. Per the terms, the pharma giant will acquire all outstanding shares of VRNA for $107 per American depositary share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results